Carol M Amato
5PUBLICATIONS
29CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Jul 28, 2023
A Population of Tumor-Infiltrating CD4+ T Cells Co-Expressing CD38 and CD39 Is Associated with Checkpoint Inhibitor Resistance.Ankita Mitra, Brian Thompson, Ann Strange
|Jul 19, 2023
CD4 Phenotypes Are Associated with Reduced Expansion of Tumor-Infiltrating Lymphocytes in Melanoma Patients Treated with Adoptive Cell Therapy.Brian Thompson, Ann Strange, Carol M Amato
|Aug 28, 2021
A Novel Regimen for Treating Melanoma: MCL1 Inhibitors and Azacitidine.Chiara R Dart, Nabanita Mukherjee, Carol M Amato
|Oct 17, 2020
Whole-genome sequencing of acral melanoma reveals genomic complexity and diversity.Felicity Newell, James S Wilmott, Peter A Johansson
|Aug 09, 2020
Simultaneously Inhibiting BCL2 and MCL1 Is a Therapeutic Option for Patients with Advanced Melanoma.Nabanita Mukherjee, Carol M Amato, Jenette Skees
Pageof 1
Frequent Collaborators
2 joint publications
Yiqun G Shellman
2 joint publications
David Woods
2 joint publications
Jonathan Hester-McCullough
2 joint publications
Ann Strange
2 joint publications
Brian Thompson
1 joint publications
Mayumi Fujita
1 joint publications
Felicity Newell
1 joint publications
Natasa Broit
1 joint publications
Stephen H Kazakoff
1 joint publications
Conrad Leonard
